Evidence map›Paper›PMID 38438250›Full record

ArticleESC heart failure2024

Development and validation of algorithms to predict left ventricular ejection fraction class from healthcare claims data.

Damien Logeart, Maxime Doublet, Margaux Gouysse, Thibaud Damy, Richard Isnard, François Roubille

Abstract readValidation StudyMulticenter Study
In one paragraph

Article in ESC heart failure, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Damien LogeartDepartment of Cardiology, Paris Cité University, AP-HP Hôpital Lariboisière, Inserm U942, 2 rue Ambroise Paré, Paris, France.
Maxime DoubletClinityx, Boulogne-Billancourt, France.
Margaux GouysseClinityx, Boulogne-Billancourt, France.
Thibaud DamyDepartment of Cardiology and French National Reference Centre for Cardiac Amyloidosis, Hôpitaux Universitaires Henri-Mondor AP-HP, IMRB, Inserm, Université Paris-Est Créteil, Créteil, France.
Richard IsnardHôpital Pitié-Salpétrière, AP-HP, Paris, France.
François RoubilleDepartment of Cardiology, INI-CRT PhyMedExp Inserm CNRS, CHU de Montpellier, Université de Montpellier, Montpellier, France.

Funding

Amgen FoundationAstraZenecaBayerBoehringer IngelheimNovartis
6 · The paper itself

Abstract

aimsThe use of large medical or healthcare claims databases is very useful for population-based studies on the burden of heart failure (HF). Clinical characteristics and management of HF patients differ according to categories of left ventricular ejection fraction (LVEF), but this information is often missing in such databases. We aimed to develop and validate algorithms to identify LVEF in healthcare databases where the information is lacking. METHODS AND

resultsAlgorithms were built by machine learning with a random forest approach. Algorithms were trained and reinforced using the French national claims database [Système National des Données de Santé (SNDS)] and a French HF registry. Variables were age, gender, and comorbidities, which could be identified by medico-administrative code-based proxies, Anatomical Therapeutic Chemical codes for drug delivery, International Classification of Diseases (Tenth Revision) coding for hospitalizations, and administrative codes for any other type of reimbursed care. The algorithms were validated by cross-validation and against a subset of the SNDS that includes LVEF information. The areas under the receiver operating characteristic curve were 0.84 for the algorithm identifying LVEF ≤ 40% and 0.79 for the algorithms identifying LVEF < 50% and ≥50%. For LVEF ≤ 40%, the reinforced algorithm identified 50% of patients in the validation dataset with a positive predictive value of 0.88 and a specificity of 0.96. The most important predictive variables were delivery of HF medication, sex, age, hospitalization, and testing for natriuretic peptides with different orders of positive or negative importance according to the LVEF category.

conclusionsThe algorithms identify reduced or preserved LVEF in HF patients within a nationwide healthcare claims database with high positive predictive value and low rates of false positives.

Indexed as

AlgorithmsHeart FailureStroke VolumeVentricular Function, LeftAgedDatabases, FactualFemaleFranceHumansInsurance Claim ReviewMaleMiddle AgedRegistriesClaims databaseHeart failureLeft ventricular ejection fractionMachine learningRegistry records

Identifiers

PMID38438250
PMCPMC11098626

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.